Effect of training by a physician on dynamics of the use of inhaler devices to improve technique in patients with obstructive lung diseases

Aksu, Funda; Şahin, Ayşe; Şengezer, Tijen; Aksu, Kurtuluş

doi:10.2500/aap.2016.37.3969

Cited by 9 publications

(12 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…At follow up, most of the patients had a better ability to use the Respimat and only a small proportion of patients were indicated for further training. Those results underline the findings of previous studies that adequate training improves user capabilities 9,11,12,29,34,35 . In the present survey, placebo inhaler was the preferred training material for both physicians and patients.…”

Section: Discussionsupporting

confidence: 89%

“…Recent studies underline this assumption that an optimized patient teaching might have positive effects on treatment adherence and exacerbation frequency 9,10 . Consequently, well-performed and repeated patient training can be considered as an important cornerstone for successful COPD maintenance treatment [11][12][13] . However, even medical staff often lack knowledge regarding the correct handling of the various kinds of inhaler devices.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Switching COPD patients from the disposable to the new reusable Respimat soft mist inhaler: a real-world study from Switzerland

Tschacher¹,

Cadus²,

Schildge

et al. 2021

Current Medical Research and Opinion

View full text Add to dashboard Cite

Objective: The aims of the survey were to assess first experiences of Swiss COPD patients switching from the disposable to the new reusable Respimat inhaler, and to evaluate physicians and patients views of the new training material. Methods: Patients with a confirmed diagnosis of COPD using a disposable Respimat inhaler for at least three months were included. Patients demographics, COPD stage, current treatment, and comorbidities relevant for the handling of the device were assessed. Further, patients were trained on the reusable Respimat by placebo inhaler, patient brochure, video cards/demo films and SMS reminder service. After at least one cartridge change, patients gave comprehensive feedback on their satisfaction with the reusable Respimat and physicians evaluated the need for re-training. Results: 235 patients participated in the survey. Of these, 37% suffered from comorbidities restricting the handling of the Respimat. 216 (92%) patients had a better overall satisfaction with the reusable than with the disposable Respimat. Dose counter (86%), monthly preparation (81%) and daily handling (77%) were also assessed as better by most of the patients. In 80% of cases, the user ability was stated as better than for the disposable Respimat. Less than 15% of the patients required further training. Placebo inhaler was the mostly preferred training material by both, physicians (in 86% of the patients) and patients (75%). In patients with comorbidities affecting inhaler handling, overall satisfaction was also better in 86% of the patients. Conclusion:The majority of patients were satisfied with the new reusable Respimat device and proper handling could be attained using the provided training material, even in patients with restricting comorbidities.

show abstract

Section: Discussionsupporting

confidence: 89%

Section: Introductionmentioning

confidence: 99%

Switching COPD patients from the disposable to the new reusable Respimat soft mist inhaler: a real-world study from Switzerland

Tschacher¹,

Cadus²,

Schildge

et al. 2021

Current Medical Research and Opinion

View full text Add to dashboard Cite

show abstract

“…[ 1 35 ] Incorrect inhaler technique is still a major problem in the region. [ 36 ] Whenever control is not achieved despite adequate management and good inhaler technique and compliance, consultation with asthma specialists for further management of the disease should be recommended. It is also recommended to facilitate access to asthma care and enhance insurance coverage to improve accessibility to medications with special attention for biologics in the management of severe asthma.…”

Section: Challenges and Recommendations For Management Of Asthmamentioning

confidence: 99%

Challenges and recommendations for the management of asthma in the Middle East and Africa

Zeitouni

Al-Moamary

Coussa

et al. 2022

Annals of Thoracic Medicine

Self Cite

View full text Add to dashboard Cite

Clinical presentation of asthma is variable, and its diagnosis can be a major challenge in routine health-care practice, especially in low-and-middle-income countries. The aim of asthma management is to achieve optimal asthma control and to reduce the risk of asthma exacerbations and mortality. In the Middle East and in Africa (MEA), several patient- and physician-related factors lead to misdiagnosis and suboptimal management of asthma. A panel of experts comprising of specialists as well as general health-care professionals met to identify challenges and provide recommendations for the management of asthma in MEA. The major challenges identified for diagnosis of asthma were lack of adequate knowledge about the disease, lack of specialized diagnostic facilities, limited access to spirometry, and social stigma associated with asthma. The prime challenges for management of asthma in MEA were identified as overreliance on short-acting β-agonists (SABAs), underprescription of inhaled corticosteroids (ICS), nonadherence to prescribed medications, and inadequate insurance coverage for its treatment. The experts endorsed adapting the Global Initiative for Asthma guidelines at country and regional levels for effective management of asthma and to alleviate the overuse of SABAs as reliever medications. Stringent control over SABA use, discouraging over-the-counter availability of SABA, and using as-needed low-dose ICS and formoterol as rescue medications in mild cases were suggested to reduce the overreliance on SABAs. Encouraging SABA alone-free clinical practice in both outpatient and emergency department settings is also imperative. We present the recommendations for the management of asthma along with proposed regional adaptations of international guidelines for MEA.

show abstract

“…Participants' inhaler use was assessed at the baseline visit, and if the demonstration was unsuccessful according to criteria for dry powder and metered dose inhalers [8], they were trained by a study nurse to use it correctly.…”

Section: Inhalation Techniquementioning

confidence: 99%

Clinical effect on uncontrolled asthma using a novel digital automated self-management solution: a physician-blinded randomised controlled crossover trial

et al. 2019

View full text Add to dashboard Cite

IntroductionAsthmaTuner is a novel self-management system consisting of a patient app, a cloud-based storage solution and a healthcare interface. Patients use Bluetooth spirometers to measure lung function (forced expiratory volume in 1 s) and can register symptoms. They then receive immediate feedback on asthma control and an image of the correct inhaler(s) to use and the dose. The aim of this pilot study was to evaluate the effect of AsthmaTuner on symptom control and adherence compared with conventional treatment.Material and methodsThis multicentre physician-blinded crossover trial randomised patients in two groups that started with 8 weeks of AsthmaTuner or conventional treatment using a personalised printed treatment plan, with 2 weeks of washout between the crossover treatments. Participants in a primary or paediatric care setting in Sweden with asthma diagnosis, uncontrolled symptoms and Asthma Control Test (ACT) score <20 points were included. Symptom control was analysed using t-tests for the difference between the group means of the sums of ACT scores at each treatment end-visit, with 95% confidence intervals. Medical Adherence Report Scale (MARS) scores captured differences in adherence (remembering to take asthma medication) between treatment periods.ResultsThe study population consisted of 77 patients (60% females). The ACT score significantly improved with AsthmaTuner compared with conventional treatment (mean ACT difference 0.70, 95% CI 0.06–1.34; p=0.03). Adherence did not improve significantly in all participants, but did improve among those in primary care who used AsthmaTuner an average of once a week or more compared with conventional treatment (mean MARS difference 0.45, 95% CI 0.13–0.77; p=0.01).ConclusionsAsthmaTuner improved symptom control in patients with uncontrolled asthma compared with conventional treatment.

show abstract

Effect of training by a physician on dynamics of the use of inhaler devices to improve technique in patients with obstructive lung diseases

Abstract: Incorrect inhaler technique is still a problem for patients with obstructive lung diseases even in urbanized areas. Physician-provided practical training on the use of inhaler devices was an effective tool in the correction of inhaler techniques.

Cited by 9 publications

References 0 publications

Switching COPD patients from the disposable to the new reusable Respimat soft mist inhaler: a real-world study from Switzerland

Switching COPD patients from the disposable to the new reusable Respimat soft mist inhaler: a real-world study from Switzerland

Challenges and recommendations for the management of asthma in the Middle East and Africa

Clinical effect on uncontrolled asthma using a novel digital automated self-management solution: a physician-blinded randomised controlled crossover trial

Contact Info

Product

Resources

About